sharp
increas
antibiot
resist
impos
global
threat
human
health
discoveri
effect
antimicrobi
altern
need
use
probiot
combat
bacteri
pathogen
gain
rise
interest
pathogen
escherichia
coli
caus
multipl
clinic
syndrom
diarrheal
diseas
mening
urinari
tract
infect
work
evalu
efficaci
probiot
control
multidrugresist
e
coli
reduc
abil
form
biofilm
six
e
coli
resist
least
five
antibiot
ceftazidim
ampicillin
clarithromycin
amoxicillin
clavulan
acid
ceftriaxon
isol
work
prepar
cellfre
spent
media
cfsm
six
probiot
belong
genu
bifidobacterium
lactobacillu
grown
manrogosasharp
mr
broth
exhibit
strong
antibacteri
activ
inhibit
zone
mm
e
coli
isol
two
e
coli
isol
name
e
coli
resist
antibiot
subject
antibiofilm
experi
interestingli
cfsm
mr
ferment
probiot
result
inhibit
biofilm
format
b
longum
caus
highest
inhibit
case
e
coli
biofilm
l
plantarum
respons
reduct
e
coli
biofilm
hand
cfsm
skim
milk
ferment
l
helveticu
l
rhamnosu
exhibit
slight
inhibitori
activ
isol
inhibit
percentag
respect
isol
biofilm
reduc
cfsm
milk
ferment
b
longum
l
helveticu
reduct
percentag
respect
result
support
effect
use
probiot
antimicrobi
altern
erad
biofilm
form
multidrugresist
e
coli
escherichia
coli
consid
member
domin
flora
inhabit
human
colon
region
although
member
speci
harmless
intestin
lumen
acquir
virul
factor
caus
wide
rang
human
diseas
nataro
et
al
pathogen
e
coli
caus
three
clinic
syndrom
urinari
tract
infect
entericdiarrh
diseas
mening
kaper
et
al
key
mechan
e
coli
caus
enter
diseas
includ
attach
colon
intestin
mucosa
manipul
host
cell
cytoskeleton
evad
host
immun
defens
product
toxin
torr
six
categori
pathogen
e
coli
wellstudi
compris
enteropathogen
e
coli
enterotoxigen
e
coli
enteroaggreg
e
coli
enterohaemorrhag
e
coli
diffus
adher
e
coli
enteroinvas
e
coli
croxen
brett
finlay
kaper
et
al
diarrheal
diseas
caus
e
coli
worldwid
estim
nearli
million
clinic
case
death
everi
year
torr
highlight
signific
pathogen
e
coli
global
health
burden
impos
diarrheal
diseas
current
intervent
inactivateelimin
pathogen
e
coli
involv
use
antibiot
howev
mani
pathogen
strain
abl
caus
ill
becom
resist
antibiot
collignon
tadess
et
al
rise
antibiot
resist
motiv
research
find
antimicrobi
altern
probiot
gain
grow
interest
use
lactobacillu
spp
bifidobacterium
spp
probiot
combat
microbi
infect
boost
human
health
inspir
mani
studi
probiot
associ
treatment
gastroenter
chai
et
al
antibioticassoci
diarrhoea
friedman
necrot
enterocol
alfaleh
et
al
pouchiti
wall
et
al
inflammatori
bowel
diseas
schultz
allerg
disord
other
minocha
antimicrobi
activ
rang
probiot
pathogen
includ
e
coli
report
et
al
addit
downregul
virul
gene
express
e
coli
use
bioactiv
molecul
secret
probiot
describ
medellinpena
et
al
moreov
probiot
capabl
reduct
e
coli
e
coli
adhes
epitheli
cell
monolay
erdem
et
al
abil
pathogen
e
coli
form
biofilm
contribut
pathogen
document
beloin
et
al
martinezmedina
et
al
antibiofilm
activ
probiot
pathogen
e
coli
poorli
studi
aim
better
util
probiot
combat
multidrugresist
e
coli
reduc
abil
form
biofilm
bacteri
strain
use
studi
summar
tabl
six
strain
probiot
belong
genera
lactobacillu
bifidobacterium
grown
manrogosasharp
mr
oxoid
hampshir
england
agar
medium
h
co
singl
coloni
strain
transfer
mr
broth
incub
condit
h
prepar
cellfre
spent
medium
cfsm
pathogen
e
coli
isol
cultiv
clinic
specimen
intens
care
unit
icu
benha
univers
teach
hospit
sewag
water
sampl
benha
citi
collect
sampl
collect
asept
transfer
immedi
cultur
macconkey
agar
eosin
methylen
blue
agar
oxoid
follow
incub
aerob
h
isol
coloni
identifi
use
vitek
system
biomerieux
usa
prepar
milk
ferment
probiot
reconstitut
skim
milk
powder
nestl
cairo
egypt
heat
min
cool
overnight
h
fresh
cultur
six
probiot
strain
inocul
individu
milk
incub
anaerob
condit
h
suscept
test
perform
use
disc
diffus
modifi
kirbi
bauer
method
biemer
follow
antibiot
oxoid
uk
ampicillin
mg
cefotaxim
ctx
mg
amikacin
ak
mg
cefoxitin
fox
mg
amoxicillin
clavulan
acid
amc
mg
ceftriaxon
cro
mg
ciprofloxacin
cip
mg
clarithromycin
cl
mg
ceftazidim
caz
mg
result
infer
accord
clinic
laboratori
standard
institut
clsi
guidelin
clsi
prepar
cfsm
probiot
strain
perform
describ
previous
bayoumi
griffith
briefli
overnight
cultur
six
probiot
strain
grown
mr
broth
dilut
fresh
medium
allow
grow
condit
optic
densiti
nm
cellsml
cell
remov
use
centrifug
min
supernat
filtersteril
mmpores
filter
refer
cellfre
spent
medium
cfsm
case
milk
ferment
probiot
cfsm
obtain
centrifug
ferment
milk
min
supernat
filter
steril
mention
cfsm
probiot
strain
store
use
assay
e
coli
test
isol
activ
trypticas
soy
agar
oxoid
h
suspens
test
bacteria
cfuml
prepar
grow
bacterium
trypticas
soy
broth
oxoid
h
agar
diffus
method
use
determin
inhibit
zone
test
bacteria
cruz
et
al
first
bottom
layer
ml
tsa
prepar
petridish
secondli
top
layer
molten
cool
tsa
ml
mix
test
bacteria
suspens
cfuml
pour
bottom
layer
five
mm
diamet
well
prepar
plate
ml
probiot
cfsm
introduc
well
test
bacteria
incub
h
inhibit
zone
measur
millimetr
antibiofilm
assay
inoculum
prepar
initi
bacteri
inoculum
biofilm
experi
prepar
mention
previous
arora
kaur
singl
coloni
e
coli
isol
transfer
ml
nutrient
broth
oxoid
uk
incub
h
obtain
cell
exponenti
phase
antibiofilm
format
activ
cfsm
prepar
probiot
assess
previous
describ
jadhav
et
al
two
group
label
test
agent
probiot
cfsm
along
experiment
control
broth
medium
prepar
microtitr
plate
supplement
volvol
probiot
cfsm
use
suggest
previous
medellinpena
et
al
griffith
group
ml
test
antibiofilm
cfsm
prepar
ad
triplic
correspond
well
steril
microtitr
plate
sigma
aldrich
usa
except
neg
control
ml
e
coli
cultur
ad
well
group
volum
broth
medium
ad
instead
case
experiment
control
final
volum
ml
per
well
microtitr
plate
seal
incub
h
biofilm
biomass
compar
neg
control
determin
use
crystal
violet
cv
assay
result
express
percentag
inhibit
treatment
period
preced
experi
quantif
biomass
carri
cv
assay
djordjev
et
al
amount
biofilm
form
well
surfac
reflect
amount
stain
absorb
incub
cultur
medium
discard
well
well
wash
three
time
steril
distil
water
remov
loos
adher
cell
microtitr
plate
allow
airdri
dri
oven
min
final
stain
ml
crystal
violet
incub
microtitr
room
temperatur
min
well
wash
two
time
steril
distil
water
remov
excess
unabsorb
stain
estim
biofilm
densiti
absorb
determin
nm
use
autom
micropl
reader
sun
rise
tecan
inc
usa
mean
absorb
od
nm
test
organ
determin
percentag
inhibit
calcul
use
follow
formula
eq
percentag
inhibit
od
test
posit
control
well
od
neg
control
result
work
six
multidrug
resist
e
coli
isol
design
e
coli
e
coli
e
coli
e
coli
isol
intens
care
unit
sewag
water
respect
isol
resist
least
five
antibiot
ceftazidim
ampicillin
clarithromycin
amoxicillin
clavulan
acid
ceftriaxon
one
isol
show
resist
cefoxitin
addit
three
isol
intermedi
sensit
amikacin
two
isol
exhibit
intermedi
sensit
cefoxitin
ciprofloxacin
result
demonstr
multidrug
resist
pattern
exhibit
isol
e
coli
e
coli
resist
antibiot
subject
antibiofilm
experi
antibiot
resist
pattern
summar
tabl
multidrug
resist
e
coli
isol
show
sensit
cfsm
probiot
tabl
isol
inhibit
similar
extent
six
probiot
inhibit
zone
mm
highest
antibacteri
activ
observ
case
b
longum
l
acidophilu
b
bifidum
e
coli
e
coli
e
coli
inhibit
zone
mm
mm
mm
respect
respect
effect
cfsm
mr
ferment
probiot
initi
attach
e
coli
toward
biofilm
format
observ
summar
tabl
gener
two
studi
e
coli
isol
show
satisfactori
abil
form
biofilm
e
coli
strong
biofilm
former
compar
strain
interestingli
probiot
result
inhibit
biofilm
format
similar
extent
b
longum
caus
highest
inhibit
case
e
coli
l
plantarum
respons
reduct
e
coli
biofilm
e
coli
biofilm
neg
influenc
cfsm
probiot
compar
isol
hand
cfsm
skim
milk
ferment
probiot
exhibit
slight
inhibitori
activ
isol
use
l
helveticu
l
rhamnosu
inhibit
percentag
respect
unfortun
rest
probiot
strain
inhibitori
effect
biofilm
tabl
contrast
isol
greatli
affect
cfsm
ferment
milk
probiot
b
longum
l
helveticu
show
strongest
antibiofilm
activ
isol
reduct
percentag
respect
result
demonstr
promis
inhibitori
potenti
cfsm
standard
mr
broth
medium
skim
milk
ferment
probiot
biofilm
form
two
multidrug
resist
e
coli
isol
tabl
antibiot
suscept
pattern
e
coli
isol
differ
antibiot
emerg
multidrugresist
e
coli
increasingli
report
paterson
bonomo
nearli
total
e
coli
isol
mani
countri
abl
produc
extendedspectrum
betalactamas
major
belong
e
coli
isol
icu
patient
magiorako
et
al
nakai
et
al
work
e
coli
isol
resist
least
six
antibiot
differ
class
multidrug
resist
clinic
pathogen
impos
rise
threat
human
health
increas
diseas
burden
spread
previou
studi
resist
e
coli
multipl
drug
cotrimoxazol
penicillin
nitrofurantoin
high
frequenc
mubita
et
al
high
resist
rate
e
coli
strain
cefazolin
tetracyclin
ampicillin
trimethoprimsulfamethoxazol
report
li
et
al
continu
emerg
multidrug
resist
even
resist
antibiot
last
resort
led
develop
altern
intervent
strategi
combat
bacteria
pathogenesi
probiot
receiv
grow
interest
prevent
treatment
infecti
human
diseas
gastrointestin
urogenit
respiratori
even
periodont
diseas
vuotto
et
al
work
cellfre
prepar
differ
probiot
belong
lactobacillu
bifidobacterium
speci
abl
reduc
growth
drugresist
e
coli
investig
use
agar
well
diffus
method
word
inhibitori
activ
seleniumenrich
probiot
pathogen
e
coli
vitro
vivo
condit
welldocu
yang
et
al
addit
probiot
isol
yoghurt
exhibit
antibacteri
effect
common
pathogen
includ
e
coli
kaboosi
moreov
fifteen
strain
probiot
belong
mani
genera
among
lactobacillu
bifidobacterium
antibacteri
properti
gram
neg
gram
posit
bacteria
et
al
cell
free
supernat
probiot
use
evid
antibacteri
properti
due
produc
organ
acid
lower
ph
addit
bioactiv
compound
releas
probiot
bacteriocin
hydrogen
peroxid
respons
antimicrobi
properti
drider
et
al
noordiana
et
al
yang
et
al
result
support
potenti
use
probioticstheir
bioactiv
compound
antimicrobi
multidrugresist
pathogen
e
coli
biofilm
format
phenomenon
microorgan
result
persist
microbi
mass
resist
antimicrobi
agent
relat
bacteri
infect
human
infect
due
biofilm
form
staphylococcu
sp
enterobacteria
e
coli
difficult
diagnos
contribut
high
healthcar
cost
morbid
rate
balsalobr
antibiofilm
properti
probiot
biofilmform
enteropathogen
investig
although
result
obtain
far
conflict
studi
cfsm
probiot
grown
mr
broth
skim
milk
reduc
biofilm
format
two
multidrug
resist
e
coli
previou
studi
singl
strain
l
acidophilu
l
plantarum
b
longum
b
lacti
effect
displac
salmonella
typhimurium
e
coli
cell
layer
candela
et
al
addit
exopolysaccharid
produc
l
acidophilu
decreas
enterohaemorrhag
e
coli
biofilm
polyvinyl
chlorid
polystyren
surfac
affect
curli
product
gene
kim
et
al
vitro
investig
focus
bacteriocin
product
adhes
growth
inhibit
coaggreg
probiot
support
potenti
role
modul
microbi
biofilm
vuotto
et
al
conclus
antibacteri
effect
cellfre
prepar
obtain
probiot
multidrugresist
e
coli
support
effect
use
antimicrobi
altern
widen
applic
medicin
food
biopreserv
well
possibl
erad
biofilm
form
pathogen
e
coli
